2 results found.

B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Clinical Trial using ipilimumab; rituximab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I Study of Ipilimumab in Combination With Rituximab in Patients With Relapsed/Refractory CD20+ B-Cell Lymphoma.
ipilimumab; rituximab; laboratory biomarker analysis

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Clinical Trial using carfilzomib; laboratory biomarker analysis

University of Nebraska - Recruiting 19 years or older.
- Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma.
carfilzomib; laboratory biomarker analysis